Sigilon Therapeutics
Edit

Sigilon Therapeutics

http://sigilon.com/
Last activity: 03.06.2024
Active
Categories: BioTechEngineeringHumanLivingMaterialsPlatformStorage
Harnessing the full power of cell therapeutics, Cambridge, MA
Likes
260
Followers
681
Mentions
20
Location: United Kingdom, England, Cambridge
Employees: 51-200
Phone: +1 617-336-7540
Total raised: $80.3M
Founded date: 2015
Twitter
Facebook
LinkedIn
Email

Investors 3

Funding Rounds 1

DateSeriesAmountInvestors
17.03.2020Series B$80.3M-

Mentions in press and media 20

DateTitleDescription
03.06.2024Viatris Appoints Rogerio Vivaldi Coelho, M.D., to Board of DirectorsPITTSBURGH, June 3, 2024 /PRNewswire/ -- Viatris Inc. (NASDAQ: VTRS), a global healthcare company, today announced that as part of its ongoing Board refreshment efforts, Rogerio Vivaldi Coelho, M.D., has been appointed as the newest member ...
09.07.2021Bay­er takes SGLT2 hope­fuls head on with FDA ap­proval for new kid­ney dis­ease drugThe FDA on Fri­day ap­proved Bay­er Phar­ma­ceu­ti­cals’ chron­ic kid­ney dis­ease drug Keren­dia (finerenone), the first and on­ly non­s­teroidal min­er­alo­cor­ti­coid re­cep­tor an­tag­o­nist, of­fer­ing a new op­tion for CKD. While ri­v...
09.07.2021Astel­las and Seagen's Pad­cev wins full FDA ap­proval, notch­ing ex­pand­ed la­bel in tough-to-crack urothe­lial can­cerTwo years af­ter Seagen and Astel­las won a con­di­tion­al FDA ap­proval to tar­get urothe­lial can­cer, the pair’s Pad­cev drug has been giv­en a full en­dorse­ment from reg­u­la­tors. The FDA grant­ed full ap­proval and a la­bel ex­pan­si...
09.07.2021As Pfiz­er/BioN­Tech prep EUA fil­ing for Covid-19 boost­er, FDA, CDC tell Amer­i­cans they don't need one just yetWelcome back to Endpoints Weekly, your review of the week’s top biopharma headlines. Want this in your inbox every Saturday morning? Current Endpoints readers can visit their reader profile to add Endpoints Weekly. New to Endpoints? Sign up...
09.07.2021As Pfiz­er/BioN­Tech prep EUA fil­ing for Covid-19 boost­er, FDA, CDC tell Amer­i­cans they don't need one just yetNovo Holdings’ seed capital arm Novo Seeds is once again launching a new biotech, and this time it comes from the combination of two European startups. The newco will take the efforts of Denmark’s Muna Therapeutics and Belgium’s K5 Therapeu...
09.07.2021With TransCode go­ing pub­lic, in­dus­try sur­pass­es $10B IPO mark; Galect­in's in­hibitor shows PhIb suc­cess in can­cer treat­mentTransCode Ther­a­peu­tics has priced its IPO at $4 a share, and while that num­ber might be on the small­er end of IPOs this year, it sig­ni­fies the pass­ing of the $10 bil­lion mark for the in­dus­try. With $10 bil­lion raised in pub­lic ...
09.07.2021As Pfiz­er/BioN­Tech prep EUA fil­ing for Covid-19 boost­er, FDA, CDC tell Amer­i­cans they don't need one just yetAs coro­n­avirus vari­ants threat­en to pro­long the Covid-19 pan­dem­ic and spur dis­cus­sions about vac­cine boost­ers, the FDA and CDC are send­ing a clear mes­sage: They are the ones with the fi­nal say on when and for whom those boost­...
09.07.2021As Pfiz­er/BioN­Tech prep EUA fil­ing for Covid-19 boost­er, FDA, CDC tell Amer­i­cans they don't need one just yetWith the FDA finally off its back on its LentiGlobin sickle cell program, bluebird bio is heading into its big split-up with a mostly clear path for its rare disease unit. The one remaining hang-up was the status of the beta thalassemia gen...
09.07.2021As Pfiz­er/BioN­Tech prep EUA fil­ing for Covid-19 boost­er, FDA, CDC tell Amer­i­cans they don't need one just yetIn the age of Moderna, it’s rare to see storied startup machine Flagship Pioneering take a loss — let alone for a team backed by research from Bob Langer’s lab. Nevertheless, a great pedigree doesn’t mean there won’t be setbacks, a lesson a...
09.07.2021Great Danes: Two Nordic biotechs name their chief ex­ec­u­tives; Ax­el Hoos bids adieu to Glax­o­SmithK­line, be­comes CEO of small on­col­o­gy play­erBen­ny Sorensen Don’t let the short week de­ceive you. Peer Re­view has a lot to get to: → When our Nicole De­Feud­is pro­filed new Co­di­ak CMO Jen­nifer Whel­er, she al­so wrote that Ben­ny Sorensen would be tak­ing on the role of SVP of ...
Show more

Reviews 0

Sign up to leave a review

Sign up Log In